The cellular and molecular basis of hyperthermia.

By B. Hildebrandt, P. Wust, O. Ahlers, A. Dieing, G. Sreenivasa, T. Kerner, R. Felix, H. Riess. Critical reviews in oncology/hematology, 2002

1,604 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Intracranial Thermotherapy using Magnetic Nanoparticles Combined with External Beam Radiotherapy: Results of a Feasibility Study on Patients with Glioblastoma Multiforme (2006, background): “the interaction between heat and radiation dose, ranging from disturbances of repair enzymes to a specific heat sensitivity of radioresistant cells [25].”
Gold nanorod assisted near-infrared plasmonic photothermal therapy (PPTT) of squamous cell carcinoma in mice. (2008, background): “thelial swelling [44], and mictothrombosis associated with homeostatic disruption [88].”
Magnetic Nanomaterials for Hyperthermia-based Therapy and Controlled Drug Delivery (2011, background): “Finally, the principal remaining problems with MFH are invasiveness, targeting (restricting the hyperthermia effect to a specific area of interest) and achieving homogenous heat distributions within the target organ.[4, 8, 54, 142] Failure to solve these problems may lead to either insufficient trea”